glp 1 and sexual dysfunction Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease desire, a biopsychosocial model for why we don't 'see' it The Impact of Glucagon-like Peptide-1

Andrew PJ, Mayer B

diabetes approval anticipated later in 2026 Not yet approved in Canada: but worth knowing about now If you've ever wished the GLP-1 medications that have transformed diabetes care could come in a simple daily pill, without needles, refrigeration, or strict timing around meals, you may be closer to that reality than you think

Mood disturbances, such as anxiety, depression, and irritability: These mental health symptoms can indicate a severe deficiency

I appreciate that I can get dressed right after applying, as there is no greasy residue left behind

WeightWatchers partnered with Mrs&Mrthe creative, design, and branding agencyto create the new identity that represents who WeightWatchers is today: integrated, intelligent, evidence-based, and always grounded in real-life human care

Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ